These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 7523011

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases.
    Lorenz HM, Grünke M, Hieronymus T, Herrmann M, Kühnel A, Manger B, Kalden JR.
    Arthritis Rheum; 1997 Feb; 40(2):306-17. PubMed ID: 9041943
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Increased Fas and Bcl-2 expression on peripheral blood T and B lymphocytes from juvenile-onset systemic lupus erythematosus, but not from juvenile rheumatoid arthritis and juvenile dermatomyositis.
    Liphaus BL, Kiss MH, Carrasco S, Goldenstein-Schainberg C.
    Clin Dev Immunol; 2006 Feb; 13(2-4):283-7. PubMed ID: 17162369
    [Abstract] [Full Text] [Related]

  • 6. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.
    Miret C, Font J, Molina R, Garcia-Carrasco M, Filella X, Ramos M, Cervera R, Ballesta A, Ingelmo M.
    Anticancer Res; 2001 Feb; 21(4B):3053-9. PubMed ID: 11712810
    [Abstract] [Full Text] [Related]

  • 7. Anti-CD3-induced and anti-Fas-induced apoptosis in systemic lupus erythematosus (SLE).
    Bijl M, Horst G, Limburg PC, Kallenberg CG.
    Clin Exp Immunol; 2001 Jan; 123(1):127-32. PubMed ID: 11168009
    [Abstract] [Full Text] [Related]

  • 8. Fas (CD95)-transduced signal preferentially stimulates lupus peripheral T lymphocytes.
    Sakata K, Sakata A, Vela-Roch N, Espinosa R, Escalante A, Kong L, Nakabayashi T, Cheng J, Talal N, Dang H.
    Eur J Immunol; 1998 Sep; 28(9):2648-60. PubMed ID: 9754553
    [Abstract] [Full Text] [Related]

  • 9. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C, Lan-Lan W, Bei C, Jie C, Wei-Hua F.
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [Abstract] [Full Text] [Related]

  • 10. Relationship of p53 with other oncogenes, cytokines and systemic lupus erythematosus activity.
    Miret C, Molina R, Filella X, García-Carrasco M, Claver G, Ingelmo M, Ballesta A, Font J.
    Tumour Biol; 2003 Feb; 24(4):185-8. PubMed ID: 14654712
    [Abstract] [Full Text] [Related]

  • 11. Increased expression of functional Fas-ligand in activated T cells from patients with systemic lupus erythematosus.
    Kovacs B, Liossis SN, Dennis GJ, Tsokos GC.
    Autoimmunity; 1997 Feb; 25(4):213-21. PubMed ID: 9344329
    [Abstract] [Full Text] [Related]

  • 12. Increased rate of apoptosis and decreased expression of bcl-2 protein in peripheral blood lymphocytes from patients with active systemic lupus erythematosus.
    Chan EY, Ko SC, Lau CS.
    Asian Pac J Allergy Immunol; 1997 Mar; 15(1):3-7. PubMed ID: 9251841
    [Abstract] [Full Text] [Related]

  • 13. High levels of bcl-2 protein in circulating T lymphocytes, but not B lymphocytes, of patients with systemic lupus erythematosus.
    Aringer M, Wintersberger W, Steiner CW, Kiener H, Presterl E, Jaeger U, Smolen JS, Graninger WB.
    Arthritis Rheum; 1994 Oct; 37(10):1423-30. PubMed ID: 7945466
    [Abstract] [Full Text] [Related]

  • 14. Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand.
    Georgescu L, Vakkalanka RK, Elkon KB, Crow MK.
    J Clin Invest; 1997 Nov 15; 100(10):2622-33. PubMed ID: 9366578
    [Abstract] [Full Text] [Related]

  • 15. Apoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus erythematosus.
    Seki M, Ushiyama C, Seta N, Abe K, Fukazawa T, Asakawa J, Takasaki Y, Hashimoto H.
    Arthritis Rheum; 1998 May 15; 41(5):823-30. PubMed ID: 9588733
    [Abstract] [Full Text] [Related]

  • 16. The apoptosis-1/Fas protein in human systemic lupus erythematosus.
    Mysler E, Bini P, Drappa J, Ramos P, Friedman SM, Krammer PH, Elkon KB.
    J Clin Invest; 1994 Mar 15; 93(3):1029-34. PubMed ID: 7510716
    [Abstract] [Full Text] [Related]

  • 17. Enhanced CD3-mediated T lymphocyte proliferation in patients with systemic lupus erythematosus.
    Stekman IL, Blasini AM, Leon-Ponte M, Baroja ML, Abadi I, Rodriguez MA.
    Arthritis Rheum; 1991 Apr 15; 34(4):459-67. PubMed ID: 1826426
    [Abstract] [Full Text] [Related]

  • 18. Effects of dexamethasone on the expression of Fas molecules and apoptosis of lymphocytes in patients with systemic lupus erythematosus.
    Ho CY, Wong CK, Li EK, Lam WK.
    Immunol Invest; 2001 Aug 15; 30(3):231-43. PubMed ID: 11570643
    [Abstract] [Full Text] [Related]

  • 19. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
    Bijl M, van Lopik T, Limburg PC, Spronk PE, Jaegers SM, Aarden LA, Smeenk RJ, Kallenberg GG.
    J Autoimmun; 1998 Oct 15; 11(5):457-63. PubMed ID: 9802929
    [Abstract] [Full Text] [Related]

  • 20. Characterization of CD3+ CD4- CD8- (double negative) T cells in patients with systemic lupus erythematosus: activation markers.
    Anand A, Dean GS, Quereshi K, Isenberg DA, Lydyard PM.
    Lupus; 2002 Oct 15; 11(8):493-500. PubMed ID: 12220103
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.